Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

執行長

Ms. Carol Pan

員工

700

國家

ISIN

US9825691051

上市

0 Comments

分享你的想法

FAQ

M2Bio Sciences 的股票代號是什麼？▼

根據交易所不同，股票代號可能會有所差異。例如，在交易所，M2Bio Sciences 的股票以代號 WG9.STU 進行交易。

M2Bio Sciences 有多少名員工？▼

截至 April 10, 2026，公司共有 700 名員工。

M2Bio Sciences 位於哪個產業？▼

M2Bio Sciences從事於Health Care產業。

M2Bio Sciences 何時完成拆股？▼

M2Bio Sciences 最近沒有進行任何拆股。

M2Bio Sciences 的總部在哪裡？▼

M2Bio Sciences 的總部位於 US 的 Reno。